Search

Sergio Veulens Phones & Addresses

  • 1284 44Th St, Hialeah, FL 33012 (305) 826-7641
  • Miami, FL

Work

Company: Beckman coulter inc Position: Senior production scientist

Industries

Biotechnology

Resumes

Resumes

Sergio Veulens Photo 1

Senior Production Scientist

View page
Location:
Miami, FL
Industry:
Biotechnology
Work:
Beckman Coulter inc
Senior Production Scientist

Publications

Us Patents

Reagent And Method For Differential Determination Of Leukocytes In Blood

View page
US Patent:
58436081, Dec 1, 1998
Filed:
Nov 4, 1997
Appl. No.:
8/963784
Inventors:
Yi Li - Miami FL
Carole Young - Miami FL
Timothy J. Fischer - Raleigh NC
James H. Carter - Plantation FL
Sergio C. Veulens - Miami FL
Assignee:
Coulter International Corp. - Miami FL
International Classification:
G01N 3348
G01N 3100
US Classification:
436 63
Abstract:
A lytic reagent composition is provided which selectively stromatolyses red blood cells in a blood sample. In addition, a lytic reagent system is provided which enable the differentiation of at least two subpopulations of leukocytes. A method for using the lytic reagent system is also provided. Still further, the lytic reagent system find use in the determination of the hemoglobin in the blood. The lytic reagent system utilizes an ethoxylated long chain compound based lysis reagent with an acid and a solubilizer, and a hypertonic, alkaline, stabilizing reagent. The system and analysis method maintains the cellular morphology of the leukocytes and can be used to analyze normal and abnormal blood samples, fresh and aged blood, human and non-human animal blood samples, as well as other fluid samples such as bone marrow.

Reagent And Method For Differential Determination Of Leukocytes In Blood

View page
US Patent:
58175180, Oct 6, 1998
Filed:
Dec 18, 1995
Appl. No.:
8/573768
Inventors:
Yi Li - Miami FL
Carole Young - Miami FL
Sergio C. Veulens - Miami FL
Assignee:
Coulter International Corp. - Miami FL
International Classification:
G01N 3348
US Classification:
436 63
Abstract:
This invention relates to a lytic reagent and a method of using the lytic reagent for automatically determining leukocyte subpopulations in blood. More specifically, the new lytic reagent lyses red blood cells and affects the eosinophils which enables the differentiation of at least one subpopulation of leukocytes. The lytic reagent is an acidic, hypertonic aqueous solution containing alkali metal salt of alkyl sulfite, an eosinolytic agent, a nonionic surfactant and a physiological salt. When used in combination with a second lytic reagent system, one is able to obtain at least a five part differential of leukocytes using DC and RF measurements.
Sergio C Veulens from Hialeah, FL Get Report